FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine, particularly to ophthalmology. An oil-in-water emulsion and a method for preparing it for ophthalmic application is characterised by at least one prostaglandin as an active agent, and a surface-active ingredient containing a combination of at least two non-ionic surfactants.
EFFECT: group of inventions provides treating glaucoma and is characterised by high chemical stability of the prostaglandin active agent that enables long-term storage of the emulsion at room temperature.
30 cl, 7 tbl, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MICROEMULSION COMPOSITIONS | 2019 |
|
RU2787998C1 |
| OPHTHALMIC COMPOSITION | 2012 |
|
RU2639472C2 |
| COMPOSITIONS AND METHODS USED FOR DECREASING OCULAR HYPERTENSION | 1998 |
|
RU2197970C2 |
| NEW VACCINE FORMULATIONS CONTAINING SAPONIN-CONTAINING ADJUVANTS | 2010 |
|
RU2555342C2 |
| NOVEL COMPOSITIONS OF VACCINES | 2006 |
|
RU2422155C2 |
| CLOBETAZOLE COMPOSITION IN THE FORM OF OIL-IN-WATER NANO-EMULSION | 2018 |
|
RU2759901C2 |
| PHARMACEUTICAL COMPOSITIONS POSSESSING DESIRABLE BIOAVAILABILITY | 2009 |
|
RU2503453C2 |
| STABILISED OIL-IN-WATER EMULSIONS INCLUDING AGRICULTURALLY ACTIVE INGREDIENTS, AND METHODS FOR USE THEREOF AS PESTICIDES | 2009 |
|
RU2526284C2 |
| EMULSIONS OF “OIL-IN-WATER” TYPE, WHICH CONTAIN NUCLEIC ACIDS | 2012 |
|
RU2606846C2 |
| MUCROFLUIDIC OIL-IN-WATER EMULSION AND VACCINE COMPOSITIONS | 2004 |
|
RU2541809C2 |
